| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |